KCT0002651Recruiting未知
A randomized, double-blind, placebo-controlled trial of ramosetron in patients with fibromyalgia.
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional Study
Eligibility Criteria
- Ages
- 18(Year) to 80(Year) (—)
- Sex
- All
Inclusion Criteria
- •Patients between 18 and 80 years of age who meet the following criteria:
- •Disease: The definition of fibromyalgia is based on the criteria published by the American Society of Rheumatology (ACR) in 2010, and the patients who meet the following criteria are eligible.
- •1) The patients who meet the 2010 ACR criteria for fibromyalgia
- •2) No response after 4 weeks of standard medication
- •3) Pain VAS 40 and FIQ score of 45 or more
- •4) The patients who are fully informed about the study and signed the informed consent.
Exclusion Criteria
- •1) Patients complaining of pain due to other rheumatic diseases.
- •2) The patients who had a certain diseases such as uncontrolled tumors
- •3) If patients have uncontrolled illness or psychiatric illness
- •4) If patients have a history of drug addiction
- •5) Patients who are pregnant or expect to become pregnant
- •6) If there is a previous history of study drug use before 30 days
- •7) Patients with severe complications due to drug allergy
- •are excluded from this study.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Efficacy and safety study of DEB025/Alisporivir combined to Peg-IFN and Ribavirin in chronic hepatitis C genotype 1 naïve patients.Chronic Hepatitis C genotype 1 treatment-naïve patientsMedDRA version: 14.1Level: LLTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2010-022867-37-DEovartis Pharma Services AG1,040
Recruiting
Phase 1
A randomized, double-blind, placebo-controlled trial of Qidong Bufei Decoction in treating postoperative symptoms of non-small cell lung cancernon-small cell lung cancerITMCTR2100004896Guang'anmen Hospital, China Academy of Chinese Medical Sciences.
Not yet recruiting
Phase 2
The effect of Morus nigra extract on patients with liver cirrhosisiver cirrhosis.Fibrosis and cirrhosis of liverIRCT20140301016776N3Mashhad University of Medical Sciences80
Recruiting
Phase 4
A randomized, double-blind, placebo-controlled clinical trial of Shugan Jieyu Capsule on improving sleep disturbance in New Coronavirus pneumonia during convalescencePatients with sleep mood disorders during recovery from new coronavirus pneumoniaITMCTR2100004389Hubei Hospital of Traditional Chinese Medicine
Completed
Not Applicable
Effects of eating high-protein oral nutrition supplement (Nucare Active) improving muscle functioDiseases of the nervous systemKCT0007708DAESANG Life Science Corporation70